ApothéCure Inc.

ApothéCure Inc. is a Dallas, Texas-based compounding pharmacy that specializes in custom compounded formulas and nutritional supplements. The business began pharmacy operations in 1991.

Controversy
ApothéCure has been implicated in the March and April, 2007, deaths of three patients from the Pacific Northwest. The patients were each given intravenous colchicine, a toxic substance commonly used in naturopathic medicine, for treatment of back pain. The colchicine, however, was labeled incorrectly and was ten times more concentrated than listed on the vials, resulting in toxic doses. The colchicine has since been recalled as with any suspected adverse drug event.

ApothéCure was investigated in 2004 following complaints that its compounds (testosterone and growth hormones) may have been illegally dispensed to patients, including a pregnant woman. Pharmacy board officials found insufficent evidence to discipline the company, but issued a letter of warning. In the 2007 deaths, however, there may have been several violations commited, including ApothéCure being unlicensed to sell drugs in Oregon.

The Pennsylvania Department of Health issued a statewide alert in 2004 after three Pennsylvania patients had reactions following intravenous injections of the ApothéCure-supplied drug phosphatidylcholine.